Shopping Cart
- Remove All
- Your shopping cart is currently empty
Eudebeiolide B, isolated from Salvia plebeia R. Br., impedes osteoclastogenesis by modulating RANKL-induced NF-κB, c-Fos, and calcium signaling pathways, and is applicable in the study of osteoclast-related diseases [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | Inquiry | Backorder | |
50 mg | Inquiry | Backorder |
Description | Eudebeiolide B, isolated from Salvia plebeia R. Br., impedes osteoclastogenesis by modulating RANKL-induced NF-κB, c-Fos, and calcium signaling pathways, and is applicable in the study of osteoclast-related diseases [1]. |
In vitro | Eudebeiolide B (1-30 μΜ, 1 hour) inhibits RANKL-induced cellular differentiation in murine bone marrow-derived macrophages, suppressing the expression of osteoclastogenesis-related marker genes and RANKL-mediated cell signaling [1]. |
In vivo | Eudebeiolide B (5 or 10 mg/kg, administered orally once a day for 6 weeks) prevented bone loss in an ovariectomized (OVX) mouse model caused by bilateral ovariectomy (OVX) [1]. |
Alias | Plebeiolide D |
Molecular Weight | 262.3 |
Formula | C15H18O4 |
Cas No. | 1934299-51-0 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.